{"entity":{"type":"insider","cik":"0001331339","url":"/insider/0001331339","json_url":"/insider/0001331339.json","name":"Powell Fred M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":9,"first":"2008-05-27","last":"2020-11-16","span_basis":"filed_date"},"name_variants":[{"name":"Powell Fred M","source":"filing","n_filings":9,"first_seen":"2008-05-27","last_seen":"2020-11-16"}],"transactions":[{"id":2192876,"accession":"0001209191-20-058421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-058421","line_url":"/filing/0001209191-20-058421#line-1","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001331339","owner_name":"Powell Fred M","owner_display_name":"Powell Fred M","owner_url":"/insider/0001331339","role":"Officer (Executive Vice President & CFO)","role_mark":"O","role_mark_label":"Officer (Executive Vice President & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16400.0,"shares_display":"16,400","price_per_share":2.85,"price_display":"2.85","price_state":"stated","total_value":46740.0,"total_display":"46,740.00","total_whole":"46,740","shares_owned_after":646465.0,"shares_owned_after_display":"646,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-16","scope":"insider"},{"id":4627789,"accession":"0001209191-17-039337","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-039337","line_url":"/filing/0001209191-17-039337#line-1","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001331339","owner_name":"Powell Fred M","owner_display_name":"Powell Fred M","owner_url":"/insider/0001331339","role":"Officer (Senior Vice President & CFO)","role_mark":"O","role_mark_label":"Officer (Senior Vice President & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":130000.0,"shares_display":"130,000","price_per_share":2.7944,"price_display":"2.79","price_state":"stated","total_value":363272.0,"total_display":"363,272.00","total_whole":"363,272","shares_owned_after":331434.0,"shares_owned_after_display":"331,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-09","filed_date":"2017-06-13","scope":"insider"},{"id":3357725,"accession":"0001209191-16-154699","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-154699","line_url":"/filing/0001209191-16-154699#line-1","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001331339","owner_name":"Powell Fred M","owner_display_name":"Powell Fred M","owner_url":"/insider/0001331339","role":"Officer (Senior Vice President & CFO)","role_mark":"O","role_mark_label":"Officer (Senior Vice President & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":2.025,"price_display":"2.02","price_state":"stated","total_value":202500.0,"total_display":"202,500.00","total_whole":"202,500","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-09","filed_date":"2016-12-12","scope":"insider"},{"id":8403244,"accession":"0001144204-15-058089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-058089","line_url":"/filing/0001144204-15-058089#line-1","is_derivative":false,"issuer_cik":"0001327467","issuer_name":"Celator Pharmaceuticals Inc","issuer_ticker":"CPXX","issuer_name_source":null,"issuer_url":"/issuer/0001327467","owner_cik":"0001331339","owner_name":"Powell Fred M","owner_display_name":"Powell Fred M","owner_url":"/insider/0001331339","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13700.0,"shares_display":"13,700","price_per_share":1.78,"price_display":"1.78","price_state":"stated","total_value":24386.0,"total_display":"24,386.00","total_whole":"24,386","shares_owned_after":31458.0,"shares_owned_after_display":"31,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-05","filed_date":"2015-10-05","scope":"insider"},{"id":7100283,"accession":"0001144204-14-069501","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-069501","line_url":"/filing/0001144204-14-069501#line-1","is_derivative":false,"issuer_cik":"0001327467","issuer_name":"Celator Pharmaceuticals Inc","issuer_ticker":"CPXX","issuer_name_source":null,"issuer_url":"/issuer/0001327467","owner_cik":"0001331339","owner_name":"Powell Fred M","owner_display_name":"Powell Fred M","owner_url":"/insider/0001331339","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":13200.0,"total_display":"13,200.00","total_whole":"13,200","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-18","scope":"insider"},{"id":7048757,"accession":"0001144204-14-031575","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-031575","line_url":"/filing/0001144204-14-031575#line-1","is_derivative":false,"issuer_cik":"0001327467","issuer_name":"Celator Pharmaceuticals Inc","issuer_ticker":"CPXX","issuer_name_source":null,"issuer_url":"/issuer/0001327467","owner_cik":"0001331339","owner_name":"Powell Fred M","owner_display_name":"Powell Fred M","owner_url":"/insider/0001331339","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.496,"price_display":"2.50","price_state":"stated","total_value":6240.0,"total_display":"6,240.00","total_whole":"6,240","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-15","filed_date":"2014-05-16","scope":"insider"},{"id":4226886,"accession":"0001144204-13-067678","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-067678","line_url":"/filing/0001144204-13-067678#line-1","is_derivative":false,"issuer_cik":"0001327467","issuer_name":"Celator Pharmaceuticals Inc","issuer_ticker":"CPXX","issuer_name_source":null,"issuer_url":"/issuer/0001327467","owner_cik":"0001331339","owner_name":"Powell Fred M","owner_display_name":"Powell Fred M","owner_url":"/insider/0001331339","role":"Officer (VP and CFO)","role_mark":"O","role_mark_label":"Officer (VP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":8750.0,"total_display":"8,750.00","total_whole":"8,750","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-17","filed_date":"2013-12-17","scope":"insider"},{"id":5805685,"accession":"0001209191-09-040804","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-040804","line_url":"/filing/0001209191-09-040804#line-1","is_derivative":false,"issuer_cik":"0001281696","issuer_name":"BMP Sunstone CORP","issuer_ticker":"BJGP","issuer_name_source":null,"issuer_url":"/issuer/0001281696","owner_cik":"0001331339","owner_name":"Powell Fred M","owner_display_name":"Powell Fred M","owner_url":"/insider/0001331339","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":3.98,"price_display":"3.98","price_state":"stated","total_value":3980.0,"total_display":"3,980.00","total_whole":"3,980","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-13","filed_date":"2009-08-17","scope":"insider"},{"id":3583826,"accession":"0001209191-08-033099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-033099","line_url":"/filing/0001209191-08-033099#line-1","is_derivative":false,"issuer_cik":"0001281696","issuer_name":"BMP Sunstone CORP","issuer_ticker":"BJGP","issuer_name_source":null,"issuer_url":"/issuer/0001281696","owner_cik":"0001331339","owner_name":"Powell Fred M","owner_display_name":"Powell Fred M","owner_url":"/insider/0001331339","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":10125.0,"total_display":"10,125.00","total_whole":"10,125","shares_owned_after":1500.0,"shares_owned_after_display":"1,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-22","filed_date":"2008-05-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001016169","name":"ANTARES PHARMA, INC.","url":"/issuer/0001016169","role":"Officer (Executive Vice President & CFO)","n_filings":3,"first_seen":"2016-12-12","last_seen":"2020-11-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001327467","name":"Celator Pharmaceuticals Inc","url":"/issuer/0001327467","role":"Officer (VP and Chief Financial Officer)","n_filings":4,"first_seen":"2013-12-17","last_seen":"2015-10-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001281696","name":"BMP Sunstone CORP","url":"/issuer/0001281696","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2008-05-27","last_seen":"2009-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001331339","retrieved_at":"2026-08-25T22:56:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}